CO-MORBID GOUT IS ASSOCIATED WITH INCREASED CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH TYPE 2 DIABETES, BUT NOT CARDIOVASCULAR EVENTS OR MORTALITY

Abstract

Background Gout is an inflammatory arthropathy characterised by elevated serum uric acid levels. In Australia, gout has a prevalence of 1.7 - 4%.1 This increased to ∼10% in community based Australian patients with type 2 diabetes, although elevated serum uric acid did not predict cardiovascular (CV) or all-cause mortality.2 To date, the long-term outcomes of patients with diabetes and comorbid gout being followed up in the hospital out-patient setting have not been studied. Objectives To compare cardiovascular risk factors and long-term outcomes and mortality in patients with type 2 diabetes according to the presence or absence of gout. Methods 1,405 patients with type 2 diabetes were prospe..